Skip to content

Comparative Study Between Nebulised Dexmedetomidine and Nebulised Midazolam in Children Undergoing Lower Abdominal Surgeries

Comparative Study Between Nebulised Dexmedetomidine and Nebulised Midazolam in Reducing Preoperative Anxiety and Emergence Delirium in Children Undergoing Lower Abdominal Surgeries

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05872087
Enrollment
60
Registered
2023-05-24
Start date
2022-11-01
Completion date
2024-02-01
Last updated
2024-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Preoperative, Emergence Delirium

Brief summary

Comparative study between nebulised dexmedetomidine and nebulized midazolam in reducing preoperative anxiety and emergence delirium in children undergoing lower abdominal surgeries

Detailed description

Dexmedetomidine is widely used in children and is replacing midazolam as the drug of choice for preoperative anxiolysis and sedation. However, there are limited studies comparing nebulized route in reducing preoperative anxiety and emergence delirium in children undergoing lower abdominal surgeries

Interventions

DRUGNebulised Dexmeditomidine

premedication by dexmeditomidine 3mcg/kg in children undergoing lower abdominal surgeries

DRUGNebulised Midazolam

premedication by nebulised midazolam 0.3mg/kg in children undergoing lower abdominal surgeries

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
3 Years to 8 Years
Healthy volunteers
Yes

Inclusion criteria

* Children aged 3-8 years * ASA I&II * Undergoing lower abdominal surgeries for example hernia repair and circumcision

Exclusion criteria

* Children with chest infection, respiratory disease, cardiac disease * Children with mental or physical disabilities, treatment with sedatives and anticonvulsants * Parental refusal * Allergy to study drugs

Design outcomes

Primary

MeasureTime frameDescription
level of preoperative anxiety30 minutes after drug administrationThe level of anxiety of the child during separation from parents according to Parental separation anxiety scale (PSAS), with a 4-point scale as: 1=easy separation; 2=whimpers, but is easily reassured, not clinging; 3=cries and cannot be easily reassured, but not clinging to parents and 4=crying and clinging to parents
Incidence of emergence deliriumimmediate postoperativeIncidence of emergence delirium, wake up behaviour will be assessed according to Watcha scale where Score is observed values as follows: 0= asleep, 1=calm, 2=crying but can be consoled, 3=crying but cannot be consoled, 4=agitating and thrashing around

Secondary

MeasureTime frameDescription
PONVperioperativeIncidence of post-operative nausea and vomiting.
the level of sedation30 minutes after drug administrationThe level of sedation when the child first seen in the operating room 30 minutes after sedation using Ramsey sedation scale
total fentanyl useintraoperativeTotal fentanyl use during operation
recovery timeup to 2 hours postoperativeRecovery time, time between laryngeal mask removal and discharge from recovery room.
hemodynamic changesperioperativenumber of participants experienced any hemodynamic changes if more than 20% change in mean arterial pressure (MAP) and Heart Rate (HR).

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026